Related Experiment Videos
Prognostication in soft tissue sarcoma. A model with four risk factors.
B Rööser1, R Attewell, N O Berg
1Department of Orthopaedics, University Hospital, Lund, Sweden.
Cancer
|February 15, 1988
Summary
Identifying risk factors like male sex, high tumor grade, necrosis, and large size is crucial for predicting survival in soft tissue sarcoma patients. This analysis aids in stratifying patients and informing treatment decisions.
Area of Science:
- Orthopedic Oncology
- Surgical Pathology
Background:
- Soft tissue sarcomas are a heterogeneous group of tumors.
- Accurate prognostication is essential for patient management and clinical trial design.
Purpose of the Study:
- To identify independent risk factors for tumor-related death in patients with high-grade soft tissue sarcomas.
- To develop a predictive model for survival based on these risk factors.
Main Methods:
- Multivariate analysis was performed on 82 patients with histologic Grades III and IV primary soft tissue sarcoma.
- Patients underwent wide or radical surgical resection.
- Risk factors analyzed included sex, histologic grade, tumor necrosis, and tumor size.
Main Results:
- Male sex, histologic Grade IV, extensive tumor necrosis, and tumor size >10 cm were significant risk factors for death.
- Survival rates decreased significantly with an increasing number of risk factors (100% for 0-1 factors to 33% for 3-4 factors).
- The model's predictive value was confirmed in a separate cohort of 62 patients undergoing marginal surgery.
Conclusions:
- A validated risk factor model can predict survival in soft tissue sarcoma.
- The model may assist in determining eligibility for adjuvant chemotherapy trials.
- Risk stratification is key for optimizing treatment strategies in high-grade soft tissue sarcomas.